Search | IOVS | ARVO Journals

Showing 1 – 20 of 93

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Articles September 2019

Properties of the Impact of Vision Impairment and Night Vision Questionnaires Among People With Intermediate Age-Related Macular Degeneration

PDF

Myra B. McGuinness; Robert P. Finger; Zhichao Wu; Chi D. Luu; Fred K. Chen; Jenifer J. Arnold; Usha Chakravarthy; Wilson J. Heriot; Jim Runciman; Robyn H. Guymer; for the LEAD Study Group
TAGS: age-related macular degeneration, dark adaptation, questionnaires, vision, visual impairment, lead
Trans. Vis. Sci. Tech.. 2019; 8(5):3. doi: 10.1167/tvst.8.5.3

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2019

Prevalence and severity of macular holes in an ageing population from Northern Ireland

catherine Jamison; Nicola B Quinn; Usha Chakravarthy; Tunde Peto; Frank Kee; Ian Young; Bernadette McGuinness; Ruth Hogg

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3951. doi:

ARVO Annual Meeting Abstract July 2019

Comparison of Colour Fundus Photography and Ultra-wide field retinal imaging in the detection of choroidal naevi in an ageing population

Nicola B Quinn; Sophia Rachael Halliday; DAVID WRIGHT; Usha Chakravarthy; Tunde Peto; Frank Kee; Ian Young; Bernadette McGuinness; Ruth Hogg

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3955. doi:

ARVO Annual Meeting Abstract July 2019

Retinal morphology and risk factors for the development of macular atrophy during extended follow up in the IVAN trial

Usha Chakravarthy; Tunde Peto; Rebecca Evans; Simon P Harding; Barney Reeves

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4223. doi:

ARVO Annual Meeting Abstract July 2019

Clinical characteristics of diabetes and diabetic retinopathy in an ageing population - NICOLA study

Sophia Rachael Halliday; Nicola B Quinn; Ruth Hogg; Usha Chakravarthy; Tunde Peto; Frank Kee; Ian Young; Bernadette McGuinness; Sharon Cruise; DAVID WRIGHT

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1079. doi:

ARVO Annual Meeting Abstract July 2019

The associations between the original randomized allocations and neovascular lesion morphology with low luminance acuity at the extended follow up visit in the IVAN clinical trial.

Alexander Foss; Barney Reeves; Rebecca Nicole Evans; Usha Chakravarthy

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1177. doi:

ARVO Annual Meeting Abstract July 2019

Long-term clinical management of neovascular AMD and visual acuity outcome in IVAN trial participants

Barney Reeves; Rebecca Evans; Simon P Harding; Andrew Lotery; Usha Chakravarthy

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1214. doi:

ARVO Annual Meeting Abstract July 2019

Real-world outcomes from the 3-year European ILUVIEN (0.19 mg fluocinolone acetonide implant) RegIstry Safety Study (IRISS)

Frank HJ Koch; Usha Chakravarthy; Ramin Khoramnia; Simon Taylor; Clare Bailey; João Sousa

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2622. doi:

ARVO Annual Meeting Abstract July 2019

Earlier intervention is associated with improved visual outcomes in patients with persistent or recurrent diabetic edema - Clinical insights from the ILUVIEN (fluocinolone acetonide) Registry Safety Study (IRISS)

Panos Vouzounis; Simon Taylor; Usha Chakravarthy; Clare Bailey; Frank HJ Koch; João Sousa

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2630. doi:

ARVO Annual Meeting Abstract July 2019

Aflibercept in the real world – are the visual outcomes worse in patients with diabetic macular edema who have had a cataract operation?

Irene Mary Stratton; Peter Henry Scanlon; James S Talks; Usha Chakravarthy; Raj Mukherjee; Faruque Ghanchi; Sajjad Mahmood; Andrew Lotery

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2637. doi:

ARVO Annual Meeting Abstract July 2019

The Carbon Footprint of Fluorescein Angiography compared to OCT Angiography

Rhianon Reynolds; Daniel Morris; Usha Chakravarthy

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3050. doi:

ARVO Annual Meeting Abstract July 2019

Can visual function tests act as early functional biomarkers of Diabetic Retinopathy prior to clinical features?

Radha Das; Jennifer Perais; Katie Graham; Klainti Timos Naska; Sophia Halliday; Nicola B Quinn; Usha Chakravarthy; Ruth Hogg

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5317. doi:

ARVO Annual Meeting Abstract July 2019

Prevalence of Age-related macular degeneration using multi-modal retinal imaging in a population based aging cohort: the NICOLA Study

Ruth Esther Hogg; Nicola B Quinn; Tunde Peto; DAVID WRIGHT; Bernadette McGuinness; Ian Young; Frank Kee; Usha Chakravarthy

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):63. doi:

ARVO Annual Meeting Abstract July 2019

Fequency of intra- and extralesional macular atrophy in the IVAN Follow-up trial

Tunde Peto; Rebecca Evans; Barney Reeves; Usha Chakravarthy

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):84. doi:

ARVO Annual Meeting Abstract July 2019

Treatment response based on topography of retinal neovascularization in proliferative diabetic retinopathy

Sandra Halim; Amy A Kirkwood; Tunde Peto; Usha Chakravarthy; Jayashree Ramu; Philip G Hykin; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6555. doi:

ARVO Annual Meeting Abstract July 2019

Associations between variation in retinal thickness and visual function

Rebecca Nicole Evans; Usha Chakravarthy; Barney Reeves

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3456. doi:

ARVO Annual Meeting Abstract July 2018

A Multicentre Double-masked Randomised Controlled Non-Inferiority Trial comparing clinical and cost effectiveness of intravitreal therapy with ranibizumab (Lucentis) vs aflibercept (Eylea) vs bevacizumab (Avastin) for Macular Oedema due to Central Retinal Vein Occlusion [LEAVO]: Baseline patient sociodemographic and ocular characteristics.

Philip G Hykin; Joana Vasconcelas; Toby Prevost; Sobha Sivaprasad; Barry Hounsome; Usha Chakravarthy; Simon Harding; Andrew Lotery; Yit C. Yang; Piyali Sen; Jayashree Ramu; Luke Nicholson; Tunde Peto

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2569. doi:

ARVO Annual Meeting Abstract July 2018

United Kingdom multicenter Medisoft™ electronic medical record real-world audit following implant of ILUVIEN ® (fluocinolone acetonide 190 µg) – the first 3-year results from the UK

Fahd Quhill; Clare Bailey; Usha Chakravarthy; Andrew Lotery; Geeta Menon; James S Talks

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1906. doi:

ARVO Annual Meeting Abstract July 2018

Clinical characteristics of the peripheral retina in Age-related Macular Degeneration (AMD) in an ageing population.

Nicola B Quinn; David Wright; Tunde Peto; Ian Young; Frank Kee; Usha Chakravarthy; Ruth Hogg

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2408. doi:

ARVO Annual Meeting Abstract June 2017

Evaluation of Coronary Heart Disease as a Risk Factor for Sight Threatening Reticular Pseudodrusen.

Rachel Victoria McCarter; Gareth J McKay; Nicola B Quinn; Usha Chakravarthy; Tom MacGillivray; Gavin Robertson; Enrico Pellegrini; Emanuele Trucco; Michelle Williams; Tunde Peto; Baljean Dhillon; Edwin van Beek; David E Newby; Ruth E Hogg

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):27. doi:

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Properties of the Impact of Vision Impairment and Night Vision Questionnaires Among People With Intermediate Age-Related Macular Degeneration

Prevalence and severity of macular holes in an ageing population from Northern Ireland

Comparison of Colour Fundus Photography and Ultra-wide field retinal imaging in the detection of choroidal naevi in an ageing population

Retinal morphology and risk factors for the development of macular atrophy during extended follow up in the IVAN trial

Clinical characteristics of diabetes and diabetic retinopathy in an ageing population - NICOLA study

The associations between the original randomized allocations and neovascular lesion morphology with low luminance acuity at the extended follow up visit in the IVAN clinical trial.

Long-term clinical management of neovascular AMD and visual acuity outcome in IVAN trial participants

Real-world outcomes from the 3-year European ILUVIEN (0.19 mg fluocinolone acetonide implant) RegIstry Safety Study (IRISS)

Earlier intervention is associated with improved visual outcomes in patients with persistent or recurrent diabetic edema - Clinical insights from the ILUVIEN (fluocinolone acetonide) Registry Safety Study (IRISS)

Aflibercept in the real world – are the visual outcomes worse in patients with diabetic macular edema who have had a cataract operation?

The Carbon Footprint of Fluorescein Angiography compared to OCT Angiography

Can visual function tests act as early functional biomarkers of Diabetic Retinopathy prior to clinical features?

Prevalence of Age-related macular degeneration using multi-modal retinal imaging in a population based aging cohort: the NICOLA Study

Fequency of intra- and extralesional macular atrophy in the IVAN Follow-up trial

Treatment response based on topography of retinal neovascularization in proliferative diabetic retinopathy

Associations between variation in retinal thickness and visual function

United Kingdom multicenter Medisoft™ electronic medical record real-world audit following implant of ILUVIEN ® (fluocinolone acetonide 190 µg) – the first 3-year results from the UK

Clinical characteristics of the peripheral retina in Age-related Macular Degeneration (AMD) in an ageing population.

Evaluation of Coronary Heart Disease as a Risk Factor for Sight Threatening Reticular Pseudodrusen.

To View More...

You must be signed into an individual account to use this feature.